Eu Ivdd Eu Ivd Annex 2 List B On The Market πŸ‡°πŸ‡· South Korea

FREND PSA Plus

NanoEntek, Inc. Β· πŸ‡°πŸ‡· South Korea
Devices (same UDI-DI)
1
Certificates
1
Countries
6
Notified Bodies
1

Basic Information

Primary DI
08809317540481
Basic UDI-DI Code
B-08809317540481
Reference
FRPS 025
Device Types
Single use
Regulation
Eu Ivdd
Classification
Eu Ivd Annex 2 List B
Status
On The Market
Manufacturer
NanoEntek, Inc.

Additional Description

The FREND PSA Plus is designed for in vitro diagnostic use only for the quantitative measurement of total prostate specific antigen (PSA) in human serum, heparinized plasma and EDTA plasma using the FREND System. This device is indicated for the serial measurement of total PSA in serum, heparinized plasma and EDTA plasma to be used as an aid in the management of patients with prostate cancer.

CND Nomenclature Codes

Code Description
W0102030113 TOTAL PROSTATIC SPECIFIC ANTIGEN

Certificates

Type Number
IVDD Annex IV (excluding sections 4, 6) V1 064393 0011

Available In Countries

πŸ‡¨πŸ‡Ύ Cyprus πŸ‡©πŸ‡ͺ Germany πŸ‡ͺπŸ‡Έ Spain πŸ‡«πŸ‡· France πŸ‡±πŸ‡Ή Lithuania πŸ‡·πŸ‡΄ Romania

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd Annex 2 List B) and regulation (EU IVDD).

View all